Ticker · CUSIP 45826J105

NTLA

INTELLIA THERAPEUTICS INC
···Share
Holders (tracked)
15
Combined shares
27,144,327
Combined value
$242.93M
Last close
$14.16
Quarter
2025Q4
Tracked holders · last 8 quarters
+3 vs previous quarter over the last 8.
15112024Q12025Q4
Price is +58.2% vs the avg quarter-end implied price across tracked holders.

SEC event timeline

24 events
  1. +939,895 shares · 2025Q4
    Position
  2. +29,477 shares · 2025Q4
    Position
  3. −44,529 shares · 2025Q4
    Position
  4. +189,076 shares · 2025Q4
    Position
  5. +103,290 shares · 2025Q4
    Position
  6. +249,131 shares · 2025Q4
    Position
  7. −481,137 shares · 2025Q4
    Position
  8. −174,261 shares · 2025Q4
    Position
  9. +3,102,664 shares · 2025Q4
    Position
  10. +223,166 shares · 2025Q4
    Position
  11. +1,021,700 shares · 2025Q4
    Position
  12. +2,288,146 shares · 2025Q4
    Position
  13. −114,964 shares · 2025Q3
    Position
  14. +73,865 shares · 2025Q3
    Position
  15. −223,443 shares · 2025Q3
    Position
  16. +174,261 shares · 2025Q3
    Position
  17. +173,033 shares · 2025Q3
    Position
  18. +1,403,673 shares · 2025Q3
    Position
  19. +41,377 shares · 2025Q3
    Position
  20. +44,529 shares · 2025Q3
    Position
  21. −56,939 shares · 2025Q3
    Position
  22. −25,900 shares · 2025Q3
    Position
  23. −194,654 shares · 2024Q3
    Position
  24. −1,098,698 shares · 2025Q3
    Position

Insider activity

No insider transactions in the last 30 days.
Follow-the-investor returns
If you'd copied each holder of NTLA…
Cost basis inferred from each manager's quarter-over-quarter position changes. Sorted by % return on the position they're still holding.
InvestorFirst inCost basisReturnPosition value today
Paul Tudor Jones (Tudor Investment)2021Q2$9.14+55.0%$2.7M
Paul Tudor Jones (Tudor Investment)2021Q2$9.14+55.0%$2.7M
Renaissance Technologies2017Q2$9.64+46.9%$23.7M
Ray Dalio (Bridgewater Associates)2022Q1$10.91+29.8%$3.2M
D.E. Shaw & Co.2019Q4$11.27+25.6%$1.2M
D.E. Shaw & Co.2019Q4$11.27+25.6%$1.2M
AQR Capital Management2017Q2$11.96+18.4%$4.4M
T. Rowe Price2018Q1$11.97+18.3%$1.7M
Ken Griffin (Citadel Advisors)2017Q3$12.16+16.4%$10.7M
Ken Griffin (Citadel Advisors)2017Q3$12.16+16.4%$10.7M
Ken Griffin (Citadel Advisors)2017Q3$12.16+16.4%$10.7M
Izzy Englander (Millennium Mgmt)2016Q3$12.58+12.5%$1.8M
Two Sigma Investments2018Q4$17.34-18.3%$38.2M
Cathie Wood (ARK Invest)2016Q4$29.99-52.8%$201.2M
Steve Cohen (Point72)2020Q2$32.48-56.4%$341K

Who moved on this name in 2025Q4

Position changes reported for the latest quarter, grouped by direction.
Added to7
Trimmed1
Exited2

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2022Q1
16
$37.99B
2022Q2
16
$32.49B
2022Q3
15
$38.3M
2022Q4
15
$806.3M
2023Q1
12
$887.5M
2023Q2
10
$935.1M
2023Q3
10
$677.3M
2023Q4
9
$700.5M
2024Q1
11
$736.8M
2024Q2
13
$543.2M
2024Q3
12
$316.7M
2024Q4
13
$212.6M
2025Q1
11
$134.5M
2025Q2
12
$178.9M
2025Q3
12
$325.6M
2025Q4
15
$242.9M

Who owns NTLA

15 super-investors · 2025Q4
Tracked stake
27.14M
shares
Combined value
$243M
% of shares outstanding
shares-out unknown
Quarter action mix
New3Added10Trim1Sold1
#ManagerSharesValue
1Cathie Wood
ARK Invest
14.21M$128M
2D.E. Shaw & Co.5.33M$48M
3Two Sigma Investments2.70M$24M
4Renaissance Technologies1.67M$15M
5Ken Griffin
Citadel Advisors
950.3K$9M
6Ken Griffin
Citadel Advisors
754.6K$7M
7Ken Griffin
Citadel Advisors
433.1K$4M
8AQR Capital Management313.7K$3M
9Ray Dalio
Bridgewater Associates
223.2K$2M
10Paul Tudor Jones
Tudor Investment
189.1K$2M
11Izzy Englander
Millennium Mgmt
126.4K$1M
12D.E. Shaw & Co.83.1K$747K
13Steve Cohen
Point72
24.1K$217K
14Paul Tudor Jones
Tudor Investment
15.0K$135K
15T. Rowe Price122.0K$1K

Recent moves

20 transactions
Embed this chart
Paste this iframe anywhere to embed the live NTLA chart.
<iframe src="https://openstocks.me/embed/stock/NTLA" width="100%" height="480" frameborder="0" loading="lazy" title="NTLA chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>